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Abstract
Introduction—Previous work has shown that daily skin cleansing with chlorhexidine gluconate
(CHG) is effective in preventing infection in the medical intensive care unit (MICU).
Methods—A colorimetric, semi-quantitative indicator was used to measure CHG concentration
on skin (neck, antecubital fossae, inguinal areas) of patients bathed daily with CHG during MICU
stay and after discharge from MICU, when CHG bathing stopped. Skin sites were also cultured
quantitatively. The relationship between CHG concentration and microbial density on skin was
explored in a mixed effects model using gram-positive colony forming unit (CFU) counts.
Results—For 20 MICU patients studied (240 measurements), lowest CHG concentrations (0–
18.75μg/mL) and highest gram-positive CFUs were on the neck (median 1.07log10CFU,
p=0.014). CHG concentration increased post-bath and decreased over 24h(p<0.001). In parallel,
median log10CFUs decreased pre- to post-bath (0.78 to 0) and then increased over 24h to baseline
of 0.78 (p=0.001). A CHG concentration >18.75μg/mL was associated with decreased gram-
positive CFU(p=0.004). In all but 2 instances, CHG was detected on patient skin during entire
inter-bath (~24h) period (18/20(90%) patients). In 11 patients studied after MICU discharge (80
measurements), CHG skin concentrations fell below effective levels after 1–3 days.
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Conclusion—In MICU patients bathed daily with CHG, CHG concentration was inversely
associated with microbial density on skin; residual antimicrobial activity on skin persisted up to
24h. Determination of CHG concentration on patients’ skin may be useful in monitoring adequacy
of skin cleansing by healthcare workers.
INTRODUCTION
Healthcare-associated infections cause significant morbidity and mortality in intensive care
unit (ICU) patients. Numerous infection control measures have been implemented in an
effort to reduce nosocomial infections1, 2. The skin of hospitalized patients can become
colonized with microbes that serve as a source of infection, blood culture contamination, and
healthcare worker hand contamination. The density of potential pathogens on skin varies
according to body site 3. ICU patients are especially vulnerable to skin colonization and
infection with multidrug-resistant organisms due to comorbidities, antibiotic exposures, and
breaks in skin as a result of devices 4. Infection control practices such as disinfection of
patients’ skin before central venous catheter (CVC) insertion and healthcare worker hand
hygiene can reduce the number of healthcare-associated infections that originate from skin
microbes5.
Daily skin cleansing with the antiseptic agent chlorhexidine gluconate (CHG) is an
adjunctive infection control strategy that reduces the density of potential microbial
pathogens on patients’ skin and decreases infection6–9. Cleansing the skin of medical
intensive care unit (MICU) patients daily with no-rinse, 2% chlorhexidine gluconate (CHG)-
impregnated cloths (Sage Inc., Cary, IL) decreases skin colonization with vancomycin-
resistant enterococci 6, reduces vancomycin-resistant enterococcal cross-transmission and
bacteremia8, and lowers rates of blood culture contamination and CVC-associated
bloodstream infections 7, 10.
To gain a better understanding of the effective durability of CHG bathing and of the
mechanism by which CHG prevents CVC-associated bloodstream infections, we studied
several aspects of CHG skin cleansing in an MICU population using a semi-quantitative,
colorimetric CHG indicator test, quantitative skin cultures, and direct observations of CHG
bathing.
METHODS
Routine daily bathing with no-rinse 2% CHG-impregnated cloths (Sage) was introduced in
November 2005 in the MICU at Rush University Medical Center (RUMC). MICU
healthcare personnel received education on proper CHG bathing (according to the
manufacturer) prior to implementation; details of this procedure have been published
elsewhere6, 7. Nurses and patient care technicians were responsible for daily patient bathing.
Products (e.g., certain soaps and lotions) with the potential to interact with CHG and reduce
its activity were eliminated from the MICU10.
From February 2007 through May 2007, we examined the usefulness of a semi-quantitative,
colorimetric indicator test as a surrogate measure of effective skin cleansing.
Primary Objective
Our primary objective was to determine the relationship between residual CHG
concentration on patients’ skin, as determined by the semi-quantitative, colorimetric CHG
assay, and colony counts of potentially pathogenic microbes. At predetermined intervals, we
collected concurrent and anatomically-proximate samples from the skin of MICU patients
who were bathed daily with CHG; one sample was processed to determine CHG
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concentration and the other to determine microbial colonization. Patients who were in the
MICU ≥72 hours and who also had received at least one CHG bath were selected randomly
for enrollment. Patients were excluded if (1) the patient’s nurse felt the patient would be
discharged from the unit that day, (2) the patient was well enough to be self-bathing, or (3)
the patient was undergoing cardiopulmonary resuscitation at the time of planned enrollment.
Swab samples of intact skin surfaces were obtained from patients’ necks (from jaw line to
clavicle), antecubital fossae, and inguinal areas 1 hour before and 1, 4, and 23 hours after a
CHG bath. Since all patients had been in the ICU for over 72 hours and had been receiving
daily CHG skin cleansing before study participation, the 1 hour “pre-bath” and 23 hours
post-bath specimens were similar in temporal relation to CHG cleansing. Specimens for
CHG concentration determination (6.25 cm2) and culture (10cm2) were collected from
adjacent areas of skin. Demographic and clinical information such as mechanical ventilation,
presence and location of a CVC, and APACHE II score were recorded.
For MICU and non-ICU ward patients, residual CHG concentration on skin was determined
using a sterile dry swab (Arrowhead Forensics, Lenexa, KS) rubbed over the skin surface.
Swabs were placed into a test tube (one swab per tube) containing 150 μl of a freshly-
prepared solution of 5 parts cetyltrimethylammonium bromide (Sigma-Aldrich, St. Louis,
MO) and 2 parts sodium hypobromite (Sigma) with color change observed immediately. An
observer blinded to time of specimen collection determined the CHG concentration by
comparison to a defined color scale (no color change and 4 shades from light to dark red).
Quality control testing (known CHG concentrations were added to swabs, processed with
the prepared reagent and compared to the color scale) was performed daily before analysis
of clinical samples11.
For culture, swabs were inoculated onto Columbia CNA agar (Remel, Lenexa, KS) to isolate
gram-positive bacteria, MacConkey agar (Remel) to isolate gram-negative bacteria,
chromogenic agar (BBL™ CHROMagar™, BD, Franklin Lakes, NJ) specific for Candida
spp and Staphylococcus aureus, and bile esculin azide agar (BD) to isolate vancomycin-
resistant enterococci. Plates were incubated at 35°C in ambient air for 24–48 hours.
Chi-Square analysis was used for comparisons between categorical variables. A random
intercept model to explain the relationship of CHG concentration and density of gram-
positive bacteria on skin was developed and a minimum concentration of CHG needed to
significantly inhibit microbial growth on skin was determined. Gram-positive bacteria were
used in the model as they were isolated most frequently; all patients had at least one
measurement with gram-positive bacteria. Contiguous CHG concentrations were combined
based on similar levels of effect on CFU density in the model and level of statistical
significance. In this model, the repeated measure was the specific measurement episode for
each patient, and within each measurement episode, the body site of culture. Colony counts,
CHG concentration, time from bath, and body site (i.e., neck, antecubital fossae, and
inguinal areas) were variables entered into the model. Appropriate use of the mixed effects
model was tested by examining the statistical significance of the variance of the random
intercepts, and random effects were retained when significant. Statistical testing was done
with SAS v9.2 (Cary, NC), using the Proc Mixed procedure.
Second Objective
Our second objective was to determine whether variability in thoroughness of CHG skin
cleansing affected CHG concentrations on skin or density of skin microbes. Research
personnel directly observed CHG bathing of enrolled patients and graded baths using a
bathing assessment form that included grading of cleansing for the neck, antecubital, and
inguinal areas. Parameters assessed included thoroughness of bathing—whether bathers
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fully wiped over bio-occlusive dressings (as recommended) or, if the patient had a
tracheostomy, whether they thoroughly cleaned the area around it; whether bathers dried the
patient after the CHG bath (undesirable); whether visible dirt was still present following a
bath; and whether patients were bathed up to the jaw line. Results of observations were
qualitatively compared with CHG concentration and colony counts at specific body sites.
Third Objective
Our third objective was to evaluate the duration of CHG effect. We studied a cohort of
patients discharged from the MICU to a non-ICU ward; CHG cleansing was not performed
outside the ICU. Patients on the non-ICU wards bathed daily with soap and water according
to standard practice for that general medicine ward. Indicator and culture swabs of the neck
and inguinal area were collected from enrolled patients on the final day of the MICU stay
and on the first day on the ward. Patients were followed daily after transfer to a non-MICU
ward until no or minimal CHG was detected by the colorimetric assay or they were
discharged from the hospital.
Fourth Objective
Our fourth objective was to determine on a microbial population level whether decreased
susceptibility to CHG was detectable after long-term universal, daily CHG skin cleansing of
patients in the MICU. We determined the minimum inhibitory concentration (MIC) of CHG
against bacteria and yeast isolated from the skin of randomly selected patients who were
cared for in the MICU between February and May 2007, 15–18 months after CHG bathing
was introduced. Susceptibility testing was done using a microdilution method12. We also
compared the minimum effective concentration of CHG on skin to the median and
maximum MICs of CHG for all microbes.
This project was reviewed and approved by the RUMC Institutional Review Board.
RESULTS
CHG concentration and colony counts on MICU patients’ skin
Twenty MICU patients (240 measurements) were enrolled in the study; 12 were men. The
mean age of enrolled patients was 61 years (SD±16.3 years); mean body mass index was 31
(SD±8.8) and mean APACHE II score was 23.1 (SD±7.4). Ten (50%) patients had an
endotracheal tube or tracheostomy in place; 13 (65%) patients had a CVC in the internal
jugular or subclavian vein. The average number of days from hospital or MICU admission
until day of enrollment was 12 and 6, respectively.
After adjusting for patient and patient body site in the random intercept model, CHG
concentration correlated inversely with density of gram-positive bacteria on patient skin
(Figure 1). In unadjusted analysis, this relationship was most striking for gram-positive
bacteria (Figure 2a).
We found variability in CHG concentration and gram-positive microbial density by body
site. The lowest CHG concentration and highest CFU counts were observed on patient necks
(median 1.07 log10CFU, p=0.014). Compared to the neck, antecubital CFU counts were 0.61
log10lower (p=0.004) and inguinal CFU counts were 0.37 log10lower (p=0.07).
CHG concentration on skin increased immediately following a CHG bath, with the
concentration decreasing to pre-bath levels, but usually still remaining detectable over the 24
hours post-bath (p<0.001). The inguinal area more often had a higher CHG concentration
than the neck at all 4 time points measured (Table 1). In parallel, there was a decrease in
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median log10gram-positive CFUs post-bath from 0.78 to 0 with a subsequent increase over
the next 24 hours to pre-bath levels (p=0.001), and with the neck having higher mean CFU
counts than other sites (Figure 2b).
A CHG concentration of >0.001875% (18.75 μg/ml) was associated with significantly less
gram-positive CFU counts (p=0.004). For 18 (90%) of 20 patients, CHG was detected
throughout the entire ~24 hour inter-bath period. A dose response was observed between
CHG concentration and CFU decline: CHG concentrations of 0.03% to 0.06% were
associated with a 0.90 log10 reduction in CFU (p=0.004) and CHG concentrations between
0.00375% and 0.015% were associated with a 0.32 log10 reduction in CFU (p=0.02) as
compared with concentrations at or below 18.75 μg/ml (Figure 1).
Thoroughness of CHG bathing
Bathing observations revealed that inguinal area cleansing received higher bath grades,
indicating more thorough bathing, than other body sites; less thorough bathing were
observed in the neck area. Eighteen (90%) of 20 patient baths had high bath grades for the
inguinal region versus 14 (70%) of 20 for the antecubital region and 2 (11%) of 19 for the
neck region. In 7 (37%) of 19 patient baths, healthcare workers failed to cleanse skin with
CHG up to the jaw line. In 7 (35%) of 20 patient baths, healthcare workers failed to clean
with CHG over bio-occlusive dressings.
CHG concentration and colony counts on patient skin following MICU discharge
Eleven patients (80 measurements) were followed from the MICU to a non-ICU ward; all
patients were tested on day 1, 10 patients were tested through day 2, and 8 patients were
tested through day 3. The number of patients with skin CHG concentrations above the level
that was significantly associated with decreased gram-positive colony counts (18.75μg/ml)
declined over time, with no patients having a CHG concentration above this level for the
neck area by Day 2 and for the inguinal area by Day 4. At all time points, the proportion of
patients with CHG concentrations in the inguinal area that were above 18.75μg/ml was
higher than the proportion of patients with this concentration of CHG in the neck area.
Colony counts on skin for all identified microbes increased after patients left the MICU
(Figure 3). Colony counts of gram-positive bacteria and of S. aureus on patients’ skin were
higher on the day of MICU discharge than earlier in the MICU stay.
Susceptibility of Skin Isolates from MICU Patients to CHG
The median and maximum MICs of CHG for microbes isolated from the skin of MICU
patients 15 to 18 months after introduction of universal, daily CHG bathing to the MICU
were low (Table 2). All isolates had MICs below the minimum effective inhibitory
concentration of CHG on skin (18.75μg/mL).
DISCUSSION
Daily bathing with no-rinse, 2% CHG-impregnated cloths is an effective infection control
intervention in the MICU10. Routine use has led to a decrease in CVC-associated
bloodstream infections 7, 9, 10, likely due to a durable reduction in potential pathogens on
patients’ skin 13, on healthcare worker hands, and in the environment6. The current study
explains in part why daily bathing with CHG is effective. Using a semi-quantitative
colorimetric CHG indicator test, we demonstrated that CHG concentrations correlated
inversely with gram-positive colony counts on the skin of MICU patients; a concentration
>18.75μg/mL was associated with significantly decreased colony counts. CHG was detected
on the skin for up to 24 hours.
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Lower concentrations of CHG and higher colony counts were detected in the neck region,
the area noted to receive less thorough cleansing when bathing was directly observed.
Patients who were intubated or who had tracheostomy tubes in place—half of the patients
studied—may have had increased oropharyngeal and tracheal secretions that contaminated
the neck area soon after daily bathing 14. The neck region may require more frequent
cleansing in these patients to reduce the higher density of colonizing organisms on skin 15, 16
resulting from secretions. The variation in cleansing may also help explain why some CVC-
associated BSIs occur despite daily CHG bathing7. Regardless, effective concentrations of
CHG were nearly always detected at all body sites and at all time points tested when daily
CHG bathing occurred. While strict adherence to proper bathing technique should be the
goal, even imperfect application of CHG appears to have a beneficial impact.
Our data suggest, though, that bathing less frequently than daily provides less benefit; after
patients left the MICU and once regular CHG bathing was no longer occurring, CHG
concentration on skin declined and microbial growth increased. However, the microbial
burden even 1 to 3 days after leaving the MICU was significantly lower than historical
values from patients who were bathed with soap and water17, suggesting that CHG may
have some residual antiseptic activity once CHG bathing has stopped. CHG concentration
was maintained at higher levels in the inguinal area than the neck, perhaps reflecting
differential thoroughness of bathing and resultant CHG concentrations observed at those
body sites when patients were in the MICU. It is unclear why colony counts for gram-
positive bacteria and S. aureus on skin were higher on the day of MICU discharge. We
hypothesize that this finding may reflect a change in bathing practice on more stable patients
awaiting transfer to the floor; e.g., last MICU bath may have been deferred to the ward
nursing staff.
CHG MICs for microorganisms isolated from the skin of MICU patients more than one year
after the introduction to the unit of universal, daily CHG bathing were comparable to
published values for microbes identified in other clinical settings18, 19. The highest CHG
MIC observed in the small sample of microbes tested in this study was 8μg/mL which is
below the concentration of CHG on skin that was found to significantly inhibit gram
positive bacterial growth. In a related report by Edmiston, et al. of healthy volunteers who
cleansed their own skin with 2% CHG-impregnated cloths, CHG skin concentrations
measured were consistently above the MIC90 for staphylococcal isolates recovered from
study subjects’ skin11. Of note, CHG concentrations measured on patients’ skin in our study
were lower than those reported by Edmiston, et al.11. Our study design differed from
Edmiston’s in that we studied MICU patients whose skin was cleansed by healthcare
workers rather than healthy volunteers who bathed themselves. In addition, calibration of the
assay was done independently in each laboratory and may have differed.
Our study should be viewed in light of the following limitations. The sample of patients
tested was small and the period of study relatively short. We did not monitor individual-
level outcomes; e.g., we did not assess rates of CVC-associated bloodstream infections
among enrolled patients and compare them to CHG concentration or microbial colony
counts on patients’ skin. However, in a previous publication, we reported much lower CVC-
associated bloodstream infection and blood culture contamination rates after the introduction
of CHG in this MICU10. Perhaps most importantly, all patients were studied after their first
CHG bath, i.e., neither baseline cultures nor cultures from skin of control patients who were
not bathed with CHG were collected. In a prior study17 that used similar swab collection and
culture methods, we compared CHG cleansing to soap-and-water bathing and to use of a
non-medicated cleansing cloth (Figure 4). CHG cleansing was associated with lower
microbial density than the other methods across all microorganism categories.
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Understanding deficiencies in implementation of an infection prevention practice are critical
to achieving its maximum benefit. The current study suggests that education of nurses and
patient care technicians on improved cleansing of the neck region may be needed. The
success of infection control practices can be limited by compliance of healthcare
personnel 20 and direct observations to assess compliance can be inaccurate due to the
Hawthorne effect 21. Simple, minimally intrusive methods such measurement of residual
CHG concentration on skin using the semi-quantitative colorimetric CHG assay evaluated in
this study may be useful in monitoring quality of, or compliance with, CHG bathing. This
approach could help highlight areas of practice that need improvement and provide an
opportunity to maximize CHG’s beneficial effect.
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The correlation between CHG concentration and predicted gram positive colony counts (±
95% confidence limits) adjusted for patient and patient body site
ABBREVIATIONS:
CFU, colony forming units; CHG, chlorhexidine digluconate
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The relationship of mean log10 colony counts and time from CHG bath. All patients tested
had received at least one CHG bath approximately 24 hours before the pre-bath time.
Figure 2a (top): Relationship displayed by category of microbe isolated. Gram-positive
organisms included coagulase-negative staphylococci, Staphylococcus aureus,
Streptococcus spp., Aerococcus sp., Micrococcus sp., and Enterococcus spp. Gram-negative
organisms included Proteus mirabilis, Pseudomonas aeruginosa, and Acinetobacter
baumannii.
Figure 2b (bottom): Relationship for gram-positive organisms displayed by body site.
ABBREVIATION: CFUs, colony counts. VRE, vancomycin-resistant enterococcus. CHG,
chlorhexidine digluconate.
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The relationship of mean log10 colony counts and time from CHG bath by category of
microbe isolated. Gram-positive organisms included coagulase-negative staphylococci,
Staphylococcus aureus, Streptococcus spp., Aerococcus sp., Micrococcus sp., and
Enterococcus spp.
ABBREVIATIONS: VRE-vancomycin resistant enterococcus. CHG, chlorhexidine
digluconate
NOTE: Day on general ward of “0” signifies day of transfer from the medical intensive care
unit to the general ward.
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Effect of bath procedure on microbial contamination in the inguinal region.
NOTE. T1 = before bath; T2 = 0–2 hours after bath; T3 = 3–5 hours after bath; T4 = 6–8
hours after bath. CHG and non-medicated bath performed with no-rinse cloths that
contained CHG (and emollients) or only bland cleansing agents (and emollients),
respectively17.
Abbreviation. VRE-vancomycin resistant enterococcus
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